SARS-CoV-2 strain-specific anti-spike IgG ELISA utilizing spike protein produced by silkworms
Human Antibodies · 2023
DOI: 10.3233/hab-230006 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Antibodies, 2023. Verfasst von Takeyuki Goto und 15 weiteren Autor:innen. Beteiligte Einrichtung: Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences (The First Department of Internal Medicine), Fukuoka, Japan. Hauptthemen laut MEDLINE: Bombyx, COVID-19. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 18 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: A cost-effective and eco-friendly method is needed for the assessment of humoral immunity against SARS-CoV-2 in large populations. OBJECTIVE: We investigated the performance of an ELISA that uses silkworm-produced proteins to quantify the strain-specific anti-Spike IgG (anti-S IgG) titer. METHODS: The OD values for the anti-His-tag antibody, a standard material of ELISA quantification, were measured. Correlations between the ELISA for each strain and the Abbott SARS-CoV-2 IgG II Quant assay for the wild type were evaluated with serum samples from nine participants with various infection and vaccination statuses. RESULTS: Linear dose-responses were confirmed by high coefficients of determination: 0.994, 0.994, and 0.996 for the wild-type, Delta, and Omicron (BA.1) strain assays, respectively. The coefficient of determination for the wild-type and Delta strain assays was high at 0.959 and 0.892, respectively, while the Omicron strain assay had a relatively low value of 0.563. Booster vaccinees showed similar or higher titers against all strains compared to infected persons without vaccination. The Omicron-infected persons without vaccination had lower antibody titers against wild type than did the vaccinated persons. CONCLUSIONS: This study provides data indicating that the ELISA with silkworm-produced proteins makes it possible to discriminate and quantify the strain-specific anti-S IgG antibody induced by vaccination or infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences (The First Department of Internal Medicine), Fukuoka, Japan.
- R&D Department, KAICO Ltd, Fukuoka, Japan.
- Laboratory of Insect Genome Science, Graduate School of Bioresource and Bioenvironmental Sciences, Kyushu University, Fukuoka, Japan.
- Laboratory of Creative Science for Insect Industries Laboratory of Insect Genome Science, Graduate School of Bioresource and Bioenvironmental Sciences, Kyushu University, Fukuoka, Japan.
- COVID-19 Team, Fukuoka City Hospital, Fukuoka, Japan.
- Center for the Study of Global Infection, Kyushu University Hospital, Fukuoka, Japan.
Zitieren
APA
Goto, T., Sasaki, T., Chong, Y., Taniguchi, M., Lee, J. M., Masuda, A., Ebihara, T., Shiraishi, K., Tani, N., Yonekawa, A., Gondo, K., Kuwano, H., Shimono, N., Ikematsu, H., Akashi, K., & Kusakabe, T. (2023). SARS-CoV-2 strain-specific anti-spike IgG ELISA utilizing spike protein produced by silkworms. Human Antibodies. https://doi.org/10.3233/hab-230006
Vancouver
Goto T, Sasaki T, Chong Y, Taniguchi M, Lee JM, Masuda A, et al. SARS-CoV-2 strain-specific anti-spike IgG ELISA utilizing spike protein produced by silkworms. Human Antibodies. 2023. doi:10.3233/hab-230006
BibTeX
@article{Goto2023,
author = {Goto, Takeyuki and Sasaki, Tomoki and Chong, Yong and Taniguchi, Masahiro and Lee, Jae Man and Masuda, Akitsu and Ebihara, Takeru and Shiraishi, Kenichiro and Tani, Naoki and Yonekawa, Akiko and Gondo, Kei and Kuwano, Hiroyuki and Shimono, Nobuyuki and Ikematsu, Hideyuki and Akashi, Koichi and Kusakabe, Takahiro},
title = {SARS-CoV-2 strain-specific anti-spike IgG ELISA utilizing spike protein produced by silkworms},
journal = {Human Antibodies},
year = {2023},
doi = {10.3233/hab-230006}
}
EUVIMED